Patients looking for the best radiology on the Gold Coast are usually not searching for a larger waiting room or a more familiar logo. They are trying to answer a much more important question:
Where am I most likely to receive the right scan, performed properly, for the most accurate diagnosis possible?
The same question is increasingly being asked about regenerative medicine. Patients searching for PRP treatment on the Gold Coast want to know whether one PRP injection is genuinely different from another. They want to understand why one clinic collects a small tube of blood while another uses a substantially larger, more sophisticated concentrating system. They also want to know whether platelet dose, cell recovery, injection accuracy and hyaluronic acid quality actually matter.
They do and this is why our clinic adopted the philosophy:
Best, Not Standard
“Standard” has an important place in medicine. Standards establish safety requirements and define the minimum level at which an examination or treatment should be performed.[1,2]
However, a minimum standard is not necessarily the highest level of care that modern imaging or regenerative medicine can provide.
At MBR Health and Mermaid Beach Radiology, we have chosen to invest in the most advanced imaging technology, develop our own advanced clinical protocols and use ulta-high dose biological preparations.
This does not mean giving every patient the longest scan or the largest possible injection. It means working backwards from the clinical question and using the most appropriate technology, biological dose and image-guided technique to answer it.
What Does “Best Radiology” Actually Mean?
There is no single scan that is best for every patient. The best radiology examination is the one that is designed around the disease, anatomical structure or clinical risk being investigated.
A patient with possible cartilage damage needs a different MRI protocol from a patient with prostate cancer. A patient with suspected nerve entrapment needs different sequences from a patient undergoing brain volumetric assessment. A spectral CT designed to assess vascular enhancement should not necessarily use the same timing and reconstruction as a conventional abdominal CT.
Professional radiology standards are essential, but they are intended to establish minimum requirements for safe, high-quality practice.[1] The American College of Radiology similarly explains that its accreditation sequences should not be interpreted as a complete clinical examination. MRI facilities must determine appropriate spatial resolution, anatomical coverage and sequence selection according to the examination being performed.[2]
In other words, passing a technical standard does not mean that every clinic produces the same examination.[2,3]
At MBR Health we offer:
- premium, advanced, research grade imaging equipment
- scan specific MRI coils designed for more precise imaging
- Internationally recognised world-renowned sequences
- unprecedented spatial resolution and slice thickness
- world’s best motion and distortion correction
- superior signal-to-noise ratio
- world-first single acquisition multi-region CT scans
- internationally awarded radiographers, physicists and globally recognised radiologists.
This is why the question should not only be:
“Do you have an MRI or CT scanner?”
It should also be:
“What has your radiology team developed that scanner to do?”
Furthermore, MBR Health offers the highest ranked patient experience based on independent Google feedback.
The Most Advanced MRI Is Only as Good as Its Protocol
An MRI scanner does not produce one fixed type of MRI.
It is a platform capable of acquiring many different combinations of images. The protocol determines which images are obtained, how thinly they are acquired, what type of contrast is generated and what pathology can reasonably be assessed.
MRI protocol optimisation involves balancing spatial resolution, tissue contrast, signal quality, artefact control and acquisition time.[2,3] Increasing one component can affect another. Thin slices may improve anatomical detail but reduce signal. Accelerating a sequence may shorten the scan but introduce noise or artefact. Diffusion imaging may be highly sensitive to disease but can be degraded by distortion and motion.
A manufacturer therefore provides a workable starting protocol. It cannot provide the ideal protocol for every clinical question, patient population or specialist practice.
At our clinic, manufacturer protocols are the beginning of the development process—not the end.
Our 3T MRI protocols have been progressively refined by radiologists, radiographers and medical imaging scientists. Depending on the clinical question, this may include:
- high-resolution, thin-slice anatomical imaging
- advanced diffusion-weighted imaging
- distortion correction
- quantitative brain assessment
- dedicated cartilage and ligament sequences
- specialised nerve imaging
- targeted oncological protocols
- advanced prostate imaging
- research-informed whole body MRI sequences
- supplementary sequences developed for specific abnormalities
The purpose is not to call every scan “advanced”. It is to ensure that the imaging capability is actually being used when the clinical question requires it.
Is 3T MRI More Advanced?
A 3T MRI system provides greater potential signal than a lower-field scanner. That additional signal can be used to improve spatial resolution, shorten imaging time or support technically demanding sequences.[2,3]
It does not guarantee a better examination by itself.
A poorly designed 3T MRI protocol can still be inferior to a carefully designed examination on another system. The machine creates the technical opportunity. The protocol, staff and reporting expertise determine how much of that opportunity is translated into clinically useful information.
This is an important distinction for patients searching for the most advanced MRI on the Gold Coast.
The most advanced MRI should not be judged only by the number written on the side of the machine. It should be judged by what is acquired, what can be seen and whether the examination is appropriate for the clinical question.
Advanced Spectral CT: More Than a Standard CT Image
The same principle applies to CT.
A conventional CT image is based on the combined attenuation of the X-ray beam through the body. Detector-based spectral CT collects additional energy-dependent information, allowing the scan to be reconstructed and analysed in several different ways.[4]
These may include:
- virtual monoenergetic images
- iodine density maps
- effective atomic number maps
- virtual non-contrast images
- material decomposition
- urate, calcium or silicone characterisation
- improved vascular contrast
- improved lesion conspicuity in selected settings.[4]
Spectral CT iodine maps can demonstrate and quantify contrast uptake within tissues. Low-energy monoenergetic reconstructions can increase iodine conspicuity, while material decomposition may help distinguish substances that appear similar on a conventional CT image.[4]
Again, the technology alone is not enough.
Contrast volume, injection rate, scan timing, radiation dose, reconstruction energy and the clinical question all affect the final examination.
Our clinic has developed dedicated spectral CT protocols rather than relying exclusively on standard thoracic, abdominal or vascular presets. In selected examinations, these protocols are designed to optimise enhancement in the tissue being assessed and make use of spectral information that would not be available from a conventional reconstruction alone.
That is what advanced medical imaging on the Gold Coast should mean: not simply owning advanced equipment, but knowing how and when to use its additional capabilities.
The Most Accurate Diagnosis Begins Before the Scan
No clinic can promise a perfect diagnosis. Imaging has limitations, disease can be subtle and no modality detects every abnormality.
What a specialist radiology practice can do is maximise the likelihood that the right examination is selected and performed properly.
The pathway begins by asking:
- What disease are we looking for?
- Which imaging modality is most sensitive to it?
- Which anatomical structures need to be covered?
- Does the protocol require contrast, diffusion or quantitative imaging?
- What are the known blind spots of the examination?
- Is another test more appropriate?
A patient concerned about small lung nodules may require CT rather than relying on MRI. Detailed breast, prostate, bowel and cardiac assessment each require their own dedicated techniques. A whole body MRI can provide broad information, but it should not be presented as the single best test for every organ.
For us, pursuing the most accurate diagnosis possible does not mean recommending the most expensive scan. It means matching the imaging technology to the biology of the disease.
Sometimes that will be an advanced 3T MRI or spectral CT.
Sometimes it will be ultrasound, mammography, colonoscopy, pathology, PET imaging or referral to another specialist.
Best, Not Standard is not about doing more imaging. It is about choosing the imaging that is most likely to answer the question.
Why Specialised Interventional Treatments Belong in a Radiology Environment
Selecting the treatment product is only part of an interventional procedure.
The product must also reach the intended anatomical structure.
Our specialised interventional treatments are performed within an advanced radiology clinic because ultrasound, CT and MRI allow diagnosis, procedural planning and treatment delivery to remain connected.
Depending on the condition, image guidance may allow the treating radiologist to:
- identify the pathological tissue before treatment
- select a safe needle pathway
- avoid adjacent nerves, vessels and organs
- enter a specific joint compartment
- target a tendon tear or ligament injury
- place treatment around a nerve
- access a spinal, epidural or intradiscal target
- confirm the position of the needle before injecting
- compare the treated area with later imaging
This is one of the major differences between a generic injection and specialised interventional radiology on the Gold Coast.
A biologically advanced preparation cannot compensate for treatment delivered to the wrong structure.
PRP Is Not One Standard Product
The term platelet-rich plasma, or PRP, can give the impression that every preparation is broadly equivalent.
This is far from correct.
PRP is created by processing a patient’s blood to produce a plasma fraction containing more platelets than the starting blood. However, commercial systems vary substantially in the biological product they produce.[5,6]
Two injections may both be called PRP while differing in:
- initial blood-draw volume
- platelet recovery
- platelet concentration
- final injected volume
- total platelet dose
- red blood cell contamination
- neutrophil content
- monocyte and lymphocyte content
- anticoagulant
- premature platelet activation
- preparation sterility and system closure.[5,6]
Scientific groups have repeatedly called for PRP to be described by its actual composition rather than by the word “PRP” alone.[5,6]
The important measure is not simply how concentrated the product appears or how many millilitres are injected.
It is the total number of functional platelets delivered to the target, together with the other cellular and plasma components contained in the preparation.[5]
What Is the Total Platelet Dose?
The total platelet dose is determined by:
platelet concentration × injected volume
Where several treatments are administered, the cumulative platelet dose also depends on the number of injections.[5,8,10]
A very small volume of highly concentrated PRP can deliver fewer total platelets than a larger preparation with a slightly lower concentration.
This is why a clinic should know more than the centrifuge manufacturer’s claimed concentration factor.
Ideally, the clinician should understand:
- the patient’s baseline platelet count
- how efficiently the system recovers platelets
- the final platelet concentration
- the volume delivered
- the approximate total platelet dose.[5,6]
Why We Prefer a High Platelet Dose
Platelets contain and release growth factors, cytokines, chemokines and other biological signals involved in inflammation, angiogenesis, cell migration and tissue remodelling.[7] It follows that a preparation delivering very few platelets may not create the same biological signal as one delivering an adequate dose. This is now becoming clearer in clinical research. A systematic review of PRP for knee osteoarthritis found that study arms reporting significant positive outcomes at six months delivered an average of approximately 5.5 billion platelets. Studies that failed to demonstrate a significant difference delivered an average of approximately 2.3 billion platelets.[8]
A randomised study using approximately 10 billion platelets reported sustained improvements in pain, function and walking capacity for up to one year in patients with moderate knee osteoarthritis.[9]
A broader systematic review and meta-analysis subsequently identified a potential dose-response relationship in knee osteoarthritis, with favourable outcomes more commonly associated with platelet doses above 10 billion. The evidence remains less certain for many other musculoskeletal conditions.[10]
These findings do not prove that the maximum possible platelet dose should be used for every patient.
They do show why we are reluctant to choose a low-yield PRP system simply because it is cheaper, faster or requires a smaller blood draw.
For a patient seeking PRP treatment on the Gold Coast, “How much PRP is injected?” is not enough information.
A better question is:
“Approximately how many platelets does the treatment deliver?”
Platelet Quality Matters as Well as Platelet Number
Platelets need to remain sufficiently intact during processing to deliver their biological contents to the treatment site.
If they activate prematurely inside the preparation system, they may release growth factors into plasma that may be subsequently discarded. This can leave a high platelet count on paper without preserving the same functional biological product.[12]
Research comparing anticoagulants found that acid citrate dextrose and CTAD better maintained platelet structure and reduced spontaneous activation than heparin or simple citrate in the tested preparations. The PRP prepared using these anticoagulants also released more transforming growth factor beta and produced greater marrow stromal-cell proliferation in vitro.[12]
This helps explain why we consider:
- anticoagulant choice
- processing forces
- platelet recovery
- preparation time
- red blood cell contamination
- premature activation.[5,6,12]
The cheapest PRP consumable is not necessarily the most economical treatment if it fails to recover or preserve an adequate biological dose.
Why Cell Yield Matters in Bone Marrow Concentrate
Patients researching regenerative medicine commonly search Google for terms such as stem cell treatment Gold Coast or stem cell therapy Australia.
The terminology requires care.
Bone marrow aspirate concentrate is not a purified syringe of stem cells. It is a mixed, autologous cellular preparation that may contain:
- mononuclear cells
- haematopoietic progenitor cells
- a small population of stromal progenitor cells
- monocytes and lymphocytes
- platelets
- plasma proteins
- cytokines and signalling molecules.[11]
The composition depends on how the bone marrow is aspirated, the volume collected, the anatomical site, the processing system and the patient’s own biology.
For this reason, we refer to the treatment by what it actually is: bone marrow aspirate concentrate, or BMAC. We do not describe it as a guaranteed stem-cell treatment. The TGA also restricts public advertising of autologous human cell and tissue products, including stem-cell treatments.[13] This is another reason accurate terminology matters.
Within those boundaries, the underlying clinical principle remains relevant: a low-volume or poorly recovered cellular preparation may contain substantially fewer mononuclear and progenitor cells than a carefully collected, high-yield product.
As with PRP, however, the maximum possible cell count is not automatically appropriate for every procedure. The available evidence has not established one ideal cellular dose across all tissues and conditions.[11]
Our approach is to optimise collection and recovery when BMAC is clinically justified, while remaining honest about what the product contains and the limitations of the evidence.
Why We Use Higher Molecular Weight Hyaluronic Acid
Hyaluronic acid is another treatment category in which products are often presented as interchangeable.
They are not.
Hyaluronic acid products differ in:
- molecular weight
- concentration
- cross-linking
- viscosity
- elasticity
- manufacturing method
- residence time
- injection volume
- number of injections required.[14,15]
Hyaluronic acid contributes to the viscoelastic properties of synovial fluid. In osteoarthritis, an intra-articular preparation may provide mechanical lubrication while also influencing inflammatory and cellular activity within the joint.[14,15]
Meta-analyses stratifying products by molecular weight have reported greater improvements in knee osteoarthritis pain with high molecular weight preparations than with lower molecular weight formulations. In one analysis, the high molecular weight group exceeded the threshold for a clinically perceptible improvement in pain, whereas the low molecular weight group did not.[14]
Another network meta-analysis found that high molecular weight hyaluronic acid produced the greatest improvement in pain and Lequesne functional scores among the molecular-weight categories studied.[15]
This does not establish one universally superior HA product for every patient. Molecular weight is only one characteristic, and response remains variable.
It does explain why we do not select a hyaluronic acid injection solely on the basis of price.
Where hyaluronic acid is appropriate, we prefer a high-quality formulation with molecular and rheological characteristics that are supported by the available evidence.
Regenerative Medicine Requires More Than a Premium Product
A premium biological product cannot correct:
- the wrong diagnosis
- inappropriate patient selection
- inaccurate needle placement
- failure to protect the treated tissue
- poorly timed rehabilitation
- inadequate follow-up
- unrealistic expectations
This is why our model of regenerative medicine on the Gold Coast begins with diagnosis.
The pathway is:
diagnosis → treatment selection → biological preparation → image-guided delivery → protection and rehabilitation → objective follow-up
For some patients, the correct decision will be PRP, BMAC or hyaluronic acid.
For others, it may be rehabilitation, conventional medication, surgery, further investigation or no injection at all. Best, Not Standard does not mean that regenerative medicine is the best treatment for everyone.
It means that when an interventional regenerative treatment is appropriate, we do not deliberately reduce its quality to meet the cheapest or simplest version of the procedure.
Better Medicine Is Not Simply More Medicine
- A high-specification scanner does not mean every patient needs a long research protocol.
- A high-yield PRP system does not mean every tissue needs PRP.
- A cellular treatment is not justified merely because cells can be collected.
The best clinical decision may be a straightforward scan, conservative management or referral to another specialist.
Our philosophy is not based on adding complexity for its own sake. It is based on refusing to allow the limitations of a default protocol, low-yield consumable or generic workflow to determine what a patient receives.
We begin with the clinical objective and build the examination or treatment around it.
That is what we mean by:
Best, Not Standard.
What Should You Ask When Choosing a Radiology or Regenerative Medicine Clinic?
1. Is the imaging protocol designed for my clinical question?
Ask whether the examination uses a routine protocol or one specifically designed for the disease or anatomical structure being assessed.
2. Who developed the MRI or CT protocol?
Advanced imaging protocols should involve radiologists, radiographers and, where relevant, MRI physicists or medical imaging scientists.
3. Does the clinic use the advanced capabilities of its equipment?
Owning a 3T MRI or spectral CT scanner does not necessarily mean that advanced diffusion, quantitative imaging, material decomposition or dedicated reconstructions are routinely used.
4. How is PRP dose measured?
Ask whether the clinic knows the platelet concentration, injected volume and approximate total platelet dose—not merely the amount of blood collected.[5,6,8]
5. Is the injection image guided?
Ultrasound or CT guidance can be important for confirming accurate placement and avoiding adjacent structures. And the company should digitally record an image of the final needle placement on your file.
6. How will the outcome be assessed?
Clinical symptoms are important, but selected conditions may also require repeat imaging, functional assessment or another objective measure.
Related Articles
- How to choose an MRI Provider
- Why choose Spectral CT over Regular CT
- Not all Whole-Body MRI Scans are the Same
- Imaging is paid for completion not quality
- Hyaluronic acid injections, what you should Know
- Everything you need to know about PRP
- Why PRP may not have worked
Frequently Asked Questions
Below are some questions related to this article, if you have any further questions please visit our FAQs page.
1- Which is the best radiology clinic on the Gold Coast?
There is no single clinic or scan that is best for every condition. Patients should consider the equipment, protocol design, subspecialist expertise, image quality, reporting, clinical communication and whether the examination is tailored to the clinical question.
2- What makes an MRI scan more accurate?
MRI accuracy can be influenced by magnet and gradient performance, coil selection, spatial resolution, slice thickness, tissue contrast, diffusion technique, motion correction, anatomical coverage and the experience of the imaging team.[2,3]
3- Is a 3T MRI better than a 1.5T MRI?
A 3T MRI provides greater potential signal, which may support higher resolution and more advanced sequences. It is not automatically better for every examination. Protocol quality and clinical suitability remain essential.[2,3]
4- What is the most advanced MRI available on the Gold Coast?
“Most advanced” should not be judged only by field strength or machine age. Patients should ask which specialised sequences are available, how protocols have been optimised and whether the clinic has experience with the condition being investigated.
5- What is spectral CT?
Spectral CT records energy-dependent information that can be used to create iodine maps, monoenergetic images and material-specific reconstructions. These tools can improve tissue characterisation and lesion conspicuity in selected clinical settings.[4]
6- Is PRP treatment the same at every clinic?
No. PRP preparations vary in platelet dose, injected volume, leukocyte composition, red blood cell contamination, anticoagulant, activation and platelet recovery.[5,6]
7- How many platelets should a PRP injection contain?
There is no single ideal dose for every tissue. In knee osteoarthritis research, stronger and more durable outcomes have generally been associated with higher total platelet doses, including doses around or above 5–10 billion platelets. Other tissues may require different formulations and volumes.[8–11]
8- Is bone marrow concentrate a stem-cell treatment?
Bone marrow concentrate is a mixed autologous cellular preparation. It contains mononuclear cells, platelets and a relatively small population of progenitor cells. It should not be described as a purified or culture-expanded stem-cell product.[11,13]
9- Why use high molecular weight hyaluronic acid?
Some meta-analyses suggest that high molecular weight hyaluronic acid provides greater improvement in knee osteoarthritis pain and function than lower molecular weight preparations. Treatment selection still depends on the patient, joint and product characteristics.[14,15]
References
2. American College of Radiology. Clinical Image Testing: MRI. Revised 15 June 2026.
3. Glide-Hurst, C.K., Paulson, E.S., McGee, K., Tyagi, N., Hu, Y., Balter, J. and Bayouth, J. (2021), Task group 284 report: magnetic resonance imaging simulation in radiotherapy: considerations for clinical implementation, optimization, and quality assurance. Med. Phys., 48: e636-e670. https://doi.org/10.1002/mp.14695
4. Franco PN, Spasiano CM, Maino C, De Ponti E, Ragusi M, Giandola T, Terrani S, Peroni M, Corso R, Ippolito D. Principles and Applications of Dual-Layer Spectral CT in Gastrointestinal Imaging. Diagnostics (Basel). 2023 May 15;13(10):1740. doi: 10.3390/diagnostics13101740. PMID: 37238224; PMCID: PMC10217357.
5. Mautner K, Malanga GA, Smith J, Shiple B, Ibrahim V, Sampson S, Bowen JE. A call for a standard classification system for future biologic research: the rationale for new PRP nomenclature. PM R. 2015 Apr;7(4 Suppl):S53-S59. doi: 10.1016/j.pmrj.2015.02.005. PMID: 25864661.
6. Dashore S, Chouhan K, Nanda S, Sharma A. Preparation of Platelet-Rich Plasma: National IADVL PRP Taskforce Recommendations. Indian Dermatol Online J. 2021 Nov 25;12(Suppl 1):S12-S23. doi: 10.4103/idoj.idoj_269_21. PMID: 34976877; PMCID: PMC8664176.
7. Andia I, Abate M. Platelet-rich plasma: underlying biology and clinical correlates. Regen Med. 2013 Sep;8(5):645-58. doi: 10.2217/rme.13.59. PMID: 23998756..
8. Berrigan WA, Bailowitz Z, Park A, Reddy A, Liu R, Lansdown D. A Greater Platelet Dose May Yield Better Clinical Outcomes for Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Systematic Review. Arthroscopy. 2025 Mar;41(3):809-817.e2. doi: 10.1016/j.arthro.2024.03.018. Epub 2024 Mar 19. PMID: 38513880.
9. Bansal, H., Leon, J., Pont, J.L. et al. Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long term clinical efficacy. Sci Rep 11, 3971 (2021). https://doi.org/10.1038/s41598-021-83025-2
10. Berrigan W, Tao F, Kopcow J, Park AL, Allen I, Tahir P, Reddy A, Bailowitz Z. The Effect of Platelet Dose on Outcomes after Platelet Rich Plasma Injections for Musculoskeletal Conditions: A Systematic Review and Meta-Analysis. Curr Rev Musculoskelet Med. 2024 Dec;17(12):570-588. doi: 10.1007/s12178-024-09922-x. Epub 2024 Sep 27. PMID: 39331322; PMCID: PMC11652557.
11. D’Souza RS, Her YF, Hussain N, Karri J, Schatman ME, Calodney AK, Lam C, Buchheit T, Boettcher BJ, Chang Chien GC, Pritzlaff SG, Centeno C, Shapiro SA, Klasova J, Grider JS, Hubbard R, Ege E, Johnson S, Epstein MH, Kubrova E, Ramadan ME, Moreira AM, Vardhan S, Eshraghi Y, Javed S, Abdullah NM, Christo PJ, Diwan S, Hassett LC, Sayed D, Deer TR. Evidence-Based Clinical Practice Guidelines on Regenerative Medicine Treatment for Chronic Pain: A Consensus Report from a Multispecialty Working Group. J Pain Res. 2024 Sep 11;17:2951-3001. doi: 10.2147/JPR.S480559. PMID: 39282657; PMCID: PMC11402349.
12. Lei H, Gui L, Xiao R. The effect of anticoagulants on the quality and biological efficacy of platelet-rich plasma. Clin Biochem. 2009 Sep;42(13-14):1452-60. doi: 10.1016/j.clinbiochem.2009.06.012. Epub 2009 Jun 26. PMID: 19560449.
14. Hummer CD, Angst F, Ngai W, Whittington C, Yoon SS, Duarte L, Manitt C, Schemitsch E. High molecular weight Intraarticular hyaluronic acid for the treatment of knee osteoarthritis: a network meta-analysis. BMC Musculoskelet Disord. 2020 Oct 23;21(1):702. doi: 10.1186/s12891-020-03729-w. PMID: 33097031; PMCID: PMC7585216.
15. Wu YZ, Huang HT, Ho CJ, Shih CL, Chen CH, Cheng TL, Wang YC, Lin SY. Molecular Weight of Hyaluronic Acid Has Major Influence on Its Efficacy and Safety for Viscosupplementation in Hip Osteoarthritis: A Systematic Review and Meta-Analysis. Cartilage. 2021 Dec;13(1_suppl):169S-184S. doi: 10.1177/19476035211021903. Epub 2021 Jun 10. PMID: 34109828; PMCID: PMC8808882.
